Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GNVC:US

2.3600 USD 0.0100 0.43%

As of 20:10:00 ET on 05/29/2015.

Company Profile for GenVec Inc (GNVC)

GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. The Company specializes in the treatment of cancers, including pancreatic cancer, esophageal cancer, rectal cancer, and head and neck cancer. The Company is also involved in studies involving hearing loss and balance disorders. GenVec also develops vaccines for infectious diseases.

Contact Information

GenVec Inc

65 West Watkins Mill Road
Gaithersburg, MD 20878
United States
Phone: 1-240-632-0740
Fax: 1-240-632-0735

Key Executives for GenVec Inc (GNVC)

Douglas J SwirskyPresident/CEO/SecretaryDouglas E BroughChief Scientific Officer
Bryan T ButmanSenior VP:DevelopmentJames V LambertTreasurer/Controller

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil